Back to results
US 12,109,183 B2Granted
Methods and compositions including protocatechuic acid crystals for the treatment of conditions caused by an enveloped virus
OwnerLanny Leo Johnsoninventor
Life of this patent
Estimating the term…
Abstract
In embodiments, a method of treating a disease or condition caused by an enveloped virus in a mammal is disclosed including administering to the mammal a composition comprising protocatechuic acid crystals and disrupting the viral envelope of the enveloped virus. The mammal may be a human. The composition may include a pharmaceutically acceptable carrier. The enveloped virus may be a coronavirus. The enveloped virus may be a virus of the family Orthomyxoviridae.
Claims5
A method of inactivating a human enveloped influenza virus type A:
- H1N1, H1N2, and H3N2;
- human enveloped influenza virus type B;
- or human enveloped influenza virus type C comprising:
- orally administering to the human infected with human enveloped influenza virus type A:
- H1N1, H1N2, and H3N2;
- human enveloped influenza virus type B;
- or human enveloped influenza virus type C, a composition consisting of protocatechuic acid crystals;
- and
- inactivating the enveloped virus.
6 more elements
Dependencies are inferred from the claim text.